Biotech · Public company · Miami Beach, FL, US
Pasithea Therapeutics Corp.
Ticker KTTA · SEC CIK 0001841330
Track this companyFree. Adds Pasithea Therapeutics Corp. to your Dealase workspace and tells you when its record changes.
Clinical trials22 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline4
- PAS-004 CapsulePhase 1 · NF1 MutationClinicalTrials.gov · fetched Nov 12, 2026
- PAS-004 CapsulesPhase 1 · RAS MutationClinicalTrials.gov · fetched Nov 12, 2026
- PAS-004 TabletsPhase 1 · NF1 MutationClinicalTrials.gov · fetched Nov 12, 2026
- PAS-004 TabletsPhase 1 · RAS MutationClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- PAS-004 in Adults Who Have Neurofibromatosis Type 1 With Plexiform NeurofibromasPHASE1 · RECRUITING · started May 30, 2025ClinicalTrials.gov NCT06961565 · fetched Nov 12, 2026
- PAS-004 in Patients With Advanced Solid TumorsPHASE1 · RECRUITING · started Feb 29, 2024ClinicalTrials.gov NCT06299839 · fetched Nov 12, 2026
SEC filings12
- 8-K · CURRENT REPORTSEC EDGAR · filed Sep 16, 2026 · fetched Nov 12, 2026
- 8-K · CURRENT REPORTSEC EDGAR · filed Sep 9, 2026 · fetched Nov 12, 2026
- 8-K · CURRENT REPORTSEC EDGAR · filed Aug 21, 2026 · fetched Nov 12, 2026
- 10-Q · QUARTERLY REPORTSEC EDGAR · filed Aug 14, 2026 · fetched Nov 12, 2026
- 10-Q · QUARTERLY REPORTSEC EDGAR · filed May 15, 2026 · fetched Nov 12, 2026
- 8-K · CURRENT REPORTSEC EDGAR · filed May 4, 2026 · fetched Nov 12, 2026
- 10-K · ANNUAL REPORTSEC EDGAR · filed Mar 30, 2026 · fetched Nov 12, 2026
- 8-K · CURRENT REPORTSEC EDGAR · filed Feb 20, 2026 · fetched Nov 12, 2026
- 8-K · CURRENT REPORTSEC EDGAR · filed Jan 28, 2026 · fetched Nov 12, 2026
- 8-K · CURRENT REPORTSEC EDGAR · filed Dec 15, 2025 · fetched Nov 12, 2026
- 8-K · CURRENT REPORTSEC EDGAR · filed Dec 2, 2025 · fetched Nov 12, 2026
- 424B4 · PROSPECTUSSEC EDGAR · filed Dec 1, 2025 · fetched Nov 12, 2026